Lymphoma - Clinical Research | Lund University Publications

Lymphoma - Clinical Research

111 – 120 of 131

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/v1001088?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2017
Mark Frequency and clinical implications of SOX11 expression in Burkitt lymphoma
Wästerlid, Tove ^LU ; Nordström, Lena ^LU ; Freiburghaus, Catja ^LU ; Pedersen, Mette ; Nørgaard, Peter ; Gang, Anne O. ; Brown, Peter ; Dictor, Michael ^LU ; Jerkeman, Mats ^LU and Ek, Sara ^LU (2017) In Leukemia & Lymphoma 58(7). p.1760-1763
- Contribution to journal › Letter
Mark The transcriptional coregulator NAB2 is a target gene for the Wilms' tumor gene 1 protein (WT1) in leukemic cells
Nilsson, Helena Jernmark ^LU ; Montano, Giorgia ^LU ; Ullmark, Tove ^LU ; Lennartsson, Andreas ^LU ; Drott, Kristina ^LU ; Järvstråt, Linnea ^LU ; Nilsson, Björn ^LU ; Vidovic, Karina ^LU and Gullberg, Urban ^LU (2017) In Oncotarget 8(50). p.87136-87150
- Contribution to journal › Article
Mark TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy
Eskelund, Christian W. ; Dahl, Christina ; Hansen, Jakob W. ; Westman, Maj ; Kolstad, Arne ; Pedersen, Lone B. ; Montano-Almendras, Carmen P. ; Husby, Simon ; Freiburghaus, Catja ^LU and Ek, Sara ^LU , et al. (2017) In Blood 130(17). p.1903-1910
- Contribution to journal › Article
Mark Newly diagnosed and relapsed mantle cell lymphoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dreyling, M ; Campo, E ; Hermine, O ; Jerkeman, M. ^LU ; Le Gouill, S. ; Rule, Simon ; Shpilberg, Ofer ; Walewski, J. ^LU and Ladetto, M. (2017) In Annals of Oncology 28. p.62-71
- Contribution to journal › Article
Mark International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma
Maurer, Matthew J. ; Ellin, Fredrik ^LU ; Srour, Line ; Jerkeman, Mats ^LU ; Bennani, N. Nora ; Connors, Joseph M. ; Slack, Graham W. ; Smedby, Karin E. ; Ansell, Stephen M. and Link, Brian K. , et al. (2017) In Journal of Clinical Oncology 35(36). p.4019-4026
- Contribution to journal › Article
2016
Mark Season of diagnosis is associated with overall survival in patients with diffuse large B-cell lymphoma but not with Hodgkin's lymphoma - A population-based Swedish Lymphoma Register study.
SZENTKIRALYI SZEKELY, ERZSÉBET ^LU ; Lindén, Ola ^LU ; Peterson, Stefan ^LU and Jerkeman, Mats ^LU (2016) In European Journal of Haematology 97(4). p.393-398
- Contribution to journal › Article
Mark Lenalidomide-bendamustine-rituximab in untreated mantle cell lymphoma > 65 years, the Nordic Lymphoma Group phase I+II trial NLG-MCL4
Albertsson-Lindblad, Alexandra ^LU ; Kolstad, Arne ; Laurell, Anna ^LU ; Räty, Riikka ; Grønbæk, Kirsten ; Sundberg, Jan ; Pedersen, Lone Bredo ; Ralfkiær, Elisabeth ; Karjalainen-Lindsberg, Marja-Liisa and Sundström, Christer , et al. (2016) In Blood 128(14). p.1814-1820
- Contribution to journal › Article
Mark Burkitt lymphoma and diffuse large B-cell lymphoma – therapeutic strategies and pathogenetic mechanisms
Wästerlid, Tove ^LU (2016)
- Thesis › Doctoral thesis (compilation)
Mark Högintensiv cytostatikaterapi ökade överlevnad vid burkitts lymfom
Wästerlid, Tove ^LU (2016) In Läkartidningen 113(48).
- Contribution to journal › Article
2015
Mark Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.
Roghanian, Ali ; Teige, Ingrid ^LU ; Mårtensson, Linda ^LU ; Cox, Kerry L ; Kovacek, Mathilda ^LU ; Ljungars, Anne ; Mattson, Jenny ^LU ; Sundberg, Annika ; Vaughan, Andrew T and Shah, Vallari , et al. (2015) In Cancer Cell 27(4). p.473-488
- Contribution to journal › Article